[Bod Science is currently dealing with delays in the capital raise from their cornerstone investor, Antah Healthcare Group. The company had plans to raise over A$2 million, with Antah committing to $1.1 million worth of shares, giving them a 14.9% stake in the company. However, they are still waiting for approval from the Monetary Authority of Singapore to transfer the funds. Antah has assured Bod that the approval is imminent, and the funds will be transferred immediately once approved. They have also confirmed their commitment to the placement in writing twice. Settlement is expected to occur in the coming days. In other news, Emyria has appointed Greg as…
Keep Reading Latest the Tennis Update on Sportyjones.com!